Role of respiratory intermediate care units during the SARS-CoV-2 pandemic.
COVID-19
Intensive care
Intermediate care
RICU
Respiratory failure
SARS-CoV-2
Tracheostomy
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
13 Jul 2021
13 Jul 2021
Historique:
received:
15
03
2021
accepted:
09
06
2021
entrez:
14
7
2021
pubmed:
15
7
2021
medline:
17
8
2021
Statut:
epublish
Résumé
The SARS-CoV2 pandemic increased exponentially the need for both Intensive (ICU) and Intermediate Care Units (RICU). The latter are of particular importance because they can play a dual role in critical and post-critical care of COVID-19 patients. Here, we describe the setup of 2 new RICUs in our institution to face the SARS-CoV-2 pandemic and discuss the clinical characteristics and outcomes of the patients attended. Retrospective analysis of the characteristics and outcomes of COVID-19 patients admitted to 2 new RICUs built specifically in our institution to face the first wave of the SARS-CoV-2 pandemic, from April 1 until May 30, 2020. During this period, 106 COVID-19 patients were admitted to these 2 RICUs, 65 of them (61%) transferred from an ICU (step-down) and 41 (39%) from the ward or emergency room (step-up). Most of them (72%) were male and mean age was 66 ± 12 years. 31% of them required support with oxygen therapy via high-flow nasal cannula (HFNC) and 14% non-invasive ventilation (NIV). 42 of the 65 patients stepping down (65%) had a previous tracheostomy performed and most of them (74%) were successfully decannulated during their stay in the RICU. Length of stay was 7 [4-11] days. 90-day mortality was 19% being significantly higher in stepping up patients than in those transferred from the ICU (25 vs. 10% respectively; p < 0.001). RICUs are a valuable hospital resource to respond to the challenges of the SARS-CoV-2 pandemic both to treat deteriorating and recovering COVID-19 patients.
Identifiants
pubmed: 34256747
doi: 10.1186/s12890-021-01593-5
pii: 10.1186/s12890-021-01593-5
pmc: PMC8275902
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
228Informations de copyright
© 2021. The Author(s).
Références
PLoS One. 2020 Dec 16;15(12):e0243968
pubmed: 33326484
Med Intensiva (Engl Ed). 2020 Aug - Sep;44(6):363-370
pubmed: 32336551
Arch Bronconeumol (Engl Ed). 2019 Dec;55(12):634-641
pubmed: 31587917
Rev Esp Anestesiol Reanim (Engl Ed). 2020 May;67(5):261-270
pubmed: 32307151
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
PLoS One. 2020 Jul 10;15(7):e0235653
pubmed: 32649661
Eur Respir J. 2020 Nov 5;56(5):
pubmed: 32747398
Arch Bronconeumol. 2005 Sep;41(9):505-12
pubmed: 16194514
Lancet Respir Med. 2020 Jul;8(7):717-725
pubmed: 32422180
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143